Updates on Veterinary Vaccines and Vaccinology
A special issue of Vaccines (ISSN 2076-393X). This special issue belongs to the section "Veterinary Vaccines".
Deadline for manuscript submissions: closed (30 June 2024) | Viewed by 3228
Special Issue Editors
Interests: PRRSV; influenza; ASFV; vaccine development; viral pathogenesis
Special Issues, Collections and Topics in MDPI journals
Interests: vaccine formulation; immunogenicity; efficacy; effectiveness; adjuvants
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
Vaccination is the most cost-effective method for controlling infectious diseases in livestock. Mass vaccination campaigns have successfully led to the eradication of several significant diseases across various regions worldwide. The advancements in molecular biology and biotechnology have played a pivotal role in the development of modern vaccines with enhanced safety and efficacy.
This Special Issue aims to publish articles that highlight the recent advancements in the field of veterinary vaccines and vaccinology. It specifically focuses on the application of vaccines to eradicate specific veterinary pathogens within a country or region. Furthermore, the issue addresses the rational design of the next generation of vaccines, the identification of immune correlates associated with vaccine-induced protection, and the examination of the impact of vaccines on pathogen evolution.
Dr. Hiep Vu
Prof. Dr. David Scott McVey
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Vaccines is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- vaccines
- immune responses
- vaccine effectiveness
- vaccine efficacy
- vaccine development
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.
Further information on MDPI's Special Issue polices can be found here.